TFE Standardized Verdict
Avoid
Impersonal model classification
Official SEC Free Cash Flow
-$38.4M
SEC Form 10-Q (filed 2026-05-10)
Trend Episodes
Breaking Down
Multi-episode price & volume path
vs. S&P 500 Benchmark
Lagging S&P 500
Relative leadership check
Counterpoint — What Independent Investors Should Watch Out For
Core Operations Burning Cash in Latest SEC Filing
Cash runway question: operations used $38.2M of cash before $140K in capital spending — ask how long existing liquidity (11.52x current ratio) lasts without issuing new shares or debt.
3 Plain-English Questions to Ask Before Buying or Holding QURE:
- Why did QURE's capital spending push official SEC Free Cash Flow negative (-$38.4M), and when will cash generation turn positive again?
- What downside exit rule protects my portfolio if QURE's current breakdown continues?
- Are there stronger Healthcare companies generating positive SEC Free Cash Flow with healthier trend support right now?
Official U.S. SEC EDGAR Filing Snapshot (QURE)
Period Ended 2026-03-31 · Filed 2026-05-10Revenues
$3.6M
Gross Margin
93.8%
Operating Cash Flow
-$38.2M
Capital Spending (CapEx)
$140,000
Free Cash Flow
-$38.4M
Current Ratio
11.52x
Long-Term Debt
$50.3M
Subscriber Research Workbench • Founding 1000 Launch Offer
See All 36 Healthcare Stocks Rated Accumulate Right Now
Every TFE Accumulate stock requires verified positive SEC Free Cash Flow, constructive multi-episode trend durability, and S&P 500 relative strength. Unlock the full 254-stock Accumulate roster, full 2,400+ stock Screener, and personal Watchlist.
Claim Founding 1000 Access — $25 / Full Year →One-time 12-month pass (capped at 1,000 members) · Or $9.99/mo
Check Other Popular U.S. Stocks:
Research Disclosure: Standardized impersonal model publication for research use only — not personalized investment advice and not a brokerage site. Verify all filings and live quotes independently before making investment decisions.